Complete Remission in a TEMPI Syndrome Treated with a Daratumumab, Lenalidomide, and Dexamethasone-Based Regimen: A Case Report
Introduction: TEMPI syndrome is a rare and acquired condition which is characterized by five classical features: telangiectasias, erythrocytosis with elevated erythropoietin, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting. The classical treatment is based on bortez...
Zapisane w:
| Główni autorzy: | , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Karger Publishers
2024-01-01
|
| Seria: | Case Reports in Oncology |
| Hasła przedmiotowe: | |
| Dostęp online: | https://beta.karger.com/Article/FullText/535551 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|